期刊文献+

急性心肌梗死并发心源性休克的危险因素分析 被引量:32

Analysis of risk factors of cardiogenic shock secondary to acute myocardial infarction
原文传递
导出
摘要 【摘要】目的从合并症中筛选急性心肌梗死(AMI)并发心源性休克(CS)的危险因素,为临床早期识别高危患者提供依据。方法对解放军总医院1993年1月至2009年12月17年中收治的5523例AMI患者资料进行回顾性分析,根据患者是否发生CS分为两组,应用多因素logistic回归模型筛选AMI患者并发CS的危险因素。结果5523例AMI患者中有197例发生了CS,发生率为3.57%;CS组30d住院病死率明显高于非cs组[55.33%(109/197)比7.49%(399/5326),P〈0.001]。Logistic回归分析显示,年龄[优势比(OR)=1.03,95%可信区间(95%CI)为1.02。1.05,P〈0.001]、陈旧性心肌梗死(OR=1.57,95%C!为1.13~2.19,P=0.007)、陈旧性脑梗死(OR=1.98,95%CJ为1.20~3.27,P=0.008)、慢性肾功能不全(OR=1.76,95%CI为1.23—2.51,P=0.002)、肺部感染(OR=1.72,95%CI为1.17~2.52,P=0.006)是AMI并发CS的独立危险因素。受试者工作特征曲线(ROC曲线)分析显示该模型有较高的判别cs患者的能力,ROC曲线下面积(AUC)为0.81(95%CI为0.75.0.85,P〈0.001)。结论高龄、合并陈旧性心肌梗死、陈旧性脑梗死、慢性肾功能不全、肺部感染多种疾病是AMI并发CS的危险因素。 Objective To explore risk factors for cardiogenic shock (CS) secondary to acute myocardial infarction (AMI) patients arising from comorbidities so as to identify high risk patients earlier. Methods A retrospective study was conducted on 5523 patients who were hospitalized with AMI in PLA General Hospital from January 1993 to December 2009. The patients were divided into two groups based on presence or absense of CS. Logistic regression analysis was used from comorbidities to evaluate the independent risk factors for CS. Results Among 5523 hospitalized AMI patients, 197 (3.57%) developed CS. The 30-day in hospital mortality rate of CS group was significantly higher than that of non-CS group [55.33% (109/197) vs. 7.49% (399/5326), P〈0.0011- On the basis of logistic regression analysis, advanced age [odds ratio (OR)= 1.03, 95% confidence interval (95%CI) 1.02 - 1.05, P〈0.001 ~, previous attack of myocardial infarction (OR= 1.57, 95%CI 1.13 - 2.19, P=0.007), history of stroke ( OR= 1.98, 95%CI 1.20 - 3.27, P=0.008), chronic renal failure ( OR= 1.76, 95%CI 1.23 - 2.51, P=0.002) and pneumonia ( OR= 1.72, 95%CI 1.17 - 2.52, P=0.006) were independent risk factors for CS. Using receiver operator characteristic curve (ROC curve) analysis, the model was shown a good quality to judge the outcome of CS patients as the area under curve equals 0.81 (95%CI 0.75 - 0.85, P〈0.001 ). Conclusion Advanced age and comorbidities including previous myocardial infarction, previous stroke, chronic renal failure and pneumonia were independent risk factors for CS.
出处 《中华危重病急救医学》 CAS CSCD 北大核心 2013年第7期399-402,共4页 Chinese Critical Care Medicine
基金 基金项目:国家科技支撑计划项目(2009BA186803) 国家科技基础条件课题项目(2004DKA20240)
关键词 心肌梗死 急性 心源性休克 合并症 危险因素 Acute myocardial infarction Cardiogenic shock Comorbidities Risk factor
  • 相关文献

参考文献15

  • 1Goldberg RJ,Spencer FA,Gore JM. Thirty-year trends (1975 to 2005) in the magnitude of,management of,and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction:a population-based perspective[J].Circulation,2009,(9):1211-1219.doi:10.1161/CIRCULATIONAHA.108.814947.
  • 2Holmes DR Jr,Bates ER,Kleiman NS. Contemporary reperfusion therapy for cardiogenic shock:the GUSTO-Ⅰ trial experience.The GUSTO-I Investigators.Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries[J].Journal of the American College of Cardiology,1995.668-674.
  • 3Hochman JS,Buller CE,Sleeper LA. Cardiogenic shock complicating acute myocardial infarction-etiologies,management and outcome:a report from the SHOCK Trial Registry.Should we emergently revascularize Occluded Coronaries for cardiogenic shock[J].Journal of the American College of Cardiology,2000.1063-1070.
  • 4赵玉生,王士雯,卢才义,吴兴利,李玉峰,刘玲玲,晏沐阳,程芮.急性心肌梗死并发心源性休克的临床特征与救治[J].中国危重病急救医学,2004,16(3):148-150. 被引量:49
  • 5黄体钢.急性心肌梗死合并心源性休克的理论和实践[J].中国危重病急救医学,2002,14(4):246-251. 被引量:36
  • 6Yusuf S,Mehta SR,Díaz R. Challenges in the conduct of large simple trials of important generic questions in resource-poor settings:the CREATE and ECLA trial program evaluating GIK (glucose,insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction[J].American Heart Journal,2004.1068-1078.
  • 7刘尧,杨艳敏,朱俊,谭慧琼,梁岩,刘力生,丽英.急性心肌梗死合并心原性休克死亡危险因素分析[J].中华心血管病杂志,2010,38(8):695-701. 被引量:13
  • 8Hasdai D,Harrington RA,Hochman JS. Platelet glycoprotein Ⅱ b/Ⅲ a blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation[J].Journal of the American College of Cardiology,2000.685-692.
  • 9The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Ⅱ b investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes[J].New England Journal of Medicine,1996.775-782.
  • 10Goldberg RJ,Samad NA,Yarzebski J. Temporal trends in cardiogenic shock complicating acute myocardial infarction[J].New England Journal of Medicine,1999.1162-1168.

二级参考文献42

  • 1Yusuf S,Mehta SR,Díaz R,et al.Challenges in the conduct of large simple trials of important generic questions in resource-poor settings:The CREATE and ECLA trial program evaluating GIK (glucose,insulin and potassium)and low-molecular-weight heparin in acute myocardial infarction.Am Heart J,2004,148:1068-1078.
  • 2Babaev A,Frederick PD,Pasta DJ,et al.Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.JAMA,2005,294:448-454.
  • 3Hochman JS,Buller CE,Sleeper LA,et al.Cardiogenic shock complicating acute myocardial infarction--etiologies,management and outcome:a report from the SHOCK trial registry.Should we emergently revascularise occluded coronaries for cardiogenic shock? J Am Coll Cardiol,2000,36:1063-1070.
  • 4Hoehman JS,Sleeper LA,Webb JG,et al.Early revascularization in acute myocardial infarction complicated by cardiogenic shock.SHOCK investigators.Should we emergently revascularized occluded coronaried for cardiogenic shock.N Eng J Med,1999,341:625-634.
  • 5Dzavik V,Sleeper LA,Cocke TP,et al.Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock:a report from the SHOCK trial registry.Eur Heart J,2003,24:828-837.
  • 6Duvernoy CS,Bates ER.Management of cardiogenic shock attributable to acute myocardial infarction in the reperfusion era.J Intensive Care Med,2005,20:188-198.
  • 7Cotter G,Kaluski E,Blatt A,et al.L-NMMA(a nitric oxide synthase inhibitor)is effective in the treatment of cardiogenic shock.Circulation,2000,101:1358-1361.
  • 8Goldberg A,Hammerman H,Petcherski S,et al.Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction.Am J Med,2004,117:242-248.
  • 9Leor J,Goldbourt U,Reicher-Reiss H,et al.Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission:incidence,risk factors,and outcome:SPRINT study group.Am J Med,1993,94:265-273.
  • 10Tada K,Nagao K,Tanjoh K,et al.Prognostic value of blood glucose in patients with cardiogenic shock.Circ J,2006,70:1064-1069.

共引文献95

同被引文献313

引证文献32

二级引证文献241

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部